Sulfasalazine: A rare cause of acute eosinophilic pneumonia

详细信息    查看全文

• 作者：P. Nadarajan^a ; ^{sonadarp2@yahoo.ie" class="auth_mail" title="E-mail the corresponding author} ; A. Fabre^b ; E. Kelly^a
• 关键词：Eosinophilic pneumonia ; Interstitial lung disease ; Drug induced lung disease
• 刊名：Respiratory Medicine Case Reports
• 出版年：2016
• 出版时间：2016
• 年：2016
• 卷：18
• 期：Complete
• 页码：35-36
• 全文大小：401 K

文摘

Sulfasalazine is a compound of 5-aminosalicylic acid (5-ASA) and sulfapyridine joined by an azo bond. It is a widely used drug in the treatment of chronic inflammatory bowel disease. Fatal toxicity of sulfasalazine arises from its effects on the bone marrow and the resulting blood dyscrasias. Pulmonary toxicity from sulfasalazine is a rather rare finding. Here, we present the case of a patient who developed acute eosinophilic pneumonia with sulfasalazine use.